Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An update from Global Bio-chem Technology Group Co. Ltd. ( (HK:0809) ) is now available.
Global Bio-chem Technology Group Company Limited has scheduled a board meeting for 27 March 2026 to review and approve the annual results of the company and its subsidiaries for the financial year ended 31 December 2025. The board will also consider the declaration of a final dividend, which could have implications for shareholder returns and signal management’s view of the group’s financial health and cash position.
The announcement also reconfirms the current composition of the board, including two executive directors, one non-executive director and three independent non-executive directors. This board structure underpins the company’s corporate governance framework as it approaches a key financial reporting and capital allocation decision point.
The most recent analyst rating on (HK:0809) stock is a Sell with a HK$0.06 price target. To see the full list of analyst forecasts on Global Bio-chem Technology Group Co. Ltd. stock, see the HK:0809 Stock Forecast page.
More about Global Bio-chem Technology Group Co. Ltd.
Global Bio-chem Technology Group Company Limited is a Hong Kong-listed company incorporated in the Cayman Islands and engaged in the bio-chemicals sector, operating through various subsidiaries. The group is overseen by a board comprising executive, non-executive and independent non-executive directors, reflecting a conventional governance structure for a mid- to large-cap industrial issuer.
Average Trading Volume: 4,916,214
Technical Sentiment Signal: Sell
Current Market Cap: HK$1.16B
See more insights into 0809 stock on TipRanks’ Stock Analysis page.